M.Chem (Oxon), British & European Patent Attorney
Toby's patent practice lies principally in the fields of pharmaceuticals and chemistry. He specialises in drafting and prosecuting patent applications directed to pharmaceutical products (including new chemical entities, peptide and antibody therapeutics, pharmaceutical formulations, polymorphs, salts, new medical uses and dosage regimes), cosmetic products, personal care products and medical devices. He also advises clients in relation to SPCs, orphan drug designations, clinical trial exemptions and regulatory data protection.
Toby has extensive experience of opposition and appeal proceedings before the EPO, and regularly represents clients in relation to such matters. Representative matters in the pharmaceutical sector include the successful defence of key patents covering the products Velcade®, Cabometyx® and Linzess®. He has also successfully defended numerous patents directed to well-known cosmetic and personal care products, as well as patents pertaining to medical devices such as coated stents and balloon catheters. Toby is well-versed in handling cases which are the subject of litigation in Europe and other jurisdictions, especially cases in which US ANDA litigation is ongoing or envisaged.
CIPA (Fellow), EPI
Toby studied chemistry at the University of Oxford, graduating with a Master's degree (first class honours). He qualified as a British Patent Attorney and a European Patent Attorney in 2006, and also holds a certificate in intellectual property law from the University of London. Toby joined HOFFMANN EITLE in 2020 after eight years as a partner at another top-tier firm.